Advertisement

Effects of flow-stop on the metabolism of noradrenaline released by nerve stimulation in the perfused spleen

  • Margarita Dubocovich
  • S. Z. Langer
Article

Summary

The metabolic pathway of 3H-noradrenaline released spontaneously and by nerve stimulation was studied in the isolated perfused spleen of the cat. The deaminated glycol, DOPEG, (3,4 dihydroxyphenylglycol) was the main metabolite in spontaneous outflow, accounting for 62.5±1.6% of the total radioactivity (n=13). Of the total increase in radioactive products elicited by nerve stimulation at 5 Hz or 10 Hz around 30% was accounted for by the noradrenaline metabolites, particularly DOPEG and the O-methylated fraction. In the presence of 2.9×10−6 M of cocaine the total overflow of radioactivity induced by stimulation was unchanged but DOPEG formation from released noradrenaline was abolished. These findings indicate that DOPEG formation results from the recapture of the released transmitter by adrenergic nerve endings and subsequent intraneuronal deamination. The total overflow of noradrenaline was reduced by flow-stop while the metabolism of the released transmitter was increased significantly. Cocaine, 2.9×10−6 M, prevented the increase in DOPEG when stimulation was applied under flow-stop conditions. The decrease in noradrenaline overflow induced by flow-stop is partly due to the increase in the metabolism of the released transmitter.

Key words

Noradrenaline Noradrenaline Metabolites Perfused Spleen Nerve Stimulation Transmitter Overflow 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Adler-Graschinsky, E., Langer, S. Z., Rubio, M. C.: Metabolism of norepinephrine released by phenoxybenzamine in isolated guinea-pig atria. J. Pharmacol. exp. Ther. 180, 286–301 (1972).Google Scholar
  2. Anton, A. H., Sayre, D. F.: A study of the factors affecting the aluminium oxide trihydroxyindole procedures for the analysis of catecholamines. J. Pharmacol. exp. Ther. 138, 360–375 (1962).Google Scholar
  3. Burn, J. H.: Practical pharmacology. Oxford: Blackwell Scientific Publications 1952.Google Scholar
  4. Crout, J. R.: In: Standard methods of clinical chemistry. Ed. by D. Seligson, vol. 3, pp. 62–80. New York: Academic Press 1961.Google Scholar
  5. Enero, Ma. A., Langer, S. Z., Rothlin, R. P., Stefano, F. J. E.: Role of the alpha-adrenoceptor in regulating noradrenaline overflow by nerve stimulation. Brit. J. Pharmacol. 44, 672–688 (1972).Google Scholar
  6. Farnebo, L. O., Hamberger, B.: Drug induced changes in the release of 3H-noradrenaline from field stimulated rat iris. Brit. J. Pharmacol. 43, 97–106 (1971).Google Scholar
  7. Graefe, K. H., Stefano, F. J. E., Langer, S. Z.: Preferential metabolism of (-)-3H-norepinephrine through the deaminated glycol in the rat vas deferens. Biochem. Pharmacol. 22, 1147–1161 (1973).Google Scholar
  8. Hertting, G.: Effect of drugs and sympathetic denervation on noradrenaline uptake and binding in animal tissues. Pharmacol. of Cholinergic and adrenergic transmission. Proc. Soc. Intern. Pharmacol. Meeting, 1963, vol. 3, pp. 277–289. Pergamon Press 1965.Google Scholar
  9. Kirpekar, S. M., Puig, Margarita: Effect of flow-stop on noradrenaline release from normal spleens treated with cocaine, phentolamine or phenoxybenzamine. Brit. J. Pharmacol. 43, 359–369 (1971).Google Scholar
  10. Langer, S. Z.: The metabolism of 3H-noradrenaline released by electrical stimulation from the isolated nictitating membrane of the cat and from the vas deferens of the rat. J. Physiol. (Lond.) 208, 515–546 (1970).Google Scholar
  11. Langer, S. Z., Adler, E., Enero, Ma. A., Stefano, F. J. E.: The role of the alpha receptor in regulating noradrenaline overflow by nerve stimulation. XXVth. Int. Congr. Physiol. Sciences, p. 335 (1971).Google Scholar
  12. Langer, S. Z., Stefano, F. J. E., Enero, Ma. A.: Pre- and postsynaptic origin of the norepinephrine metabolites formed during transmitter release elicited by nerve stimulation. J. Pharmacol. exp. Ther. 183, 90–102 (1972).Google Scholar
  13. Laverty, R., Taylor, K. M.: The fluorometric assay of catecholamines and related compounds: Improvements and extensions to the hydroxyindole technique. Analyt. Biochem. 22, 269–279 (1968).Google Scholar
  14. Levin, J. A.: Metabolism of 3H-norepinephrine by the adventitia and media of rabbit aorta. V th. Int. Congr. Pharmac., p. 139 (1972).Google Scholar
  15. Paton, D. M., Gillis, G. N.: Effect of altered perfusion rates on the retention of noradrenaline by the spleen. Nature (Lond.) 208, 391–392 (1965).Google Scholar
  16. Roffler-Tarlov, S., Langer, S. Z.: The fate of 3H-norepinephrine released from isolated atria and vas deferens: effect of field stimulation J. Pharmacol. exp. Ther. 179, 186–197 (1971).Google Scholar
  17. Snedecor, G. W., Cochran, W. G.: Statistical methods, 6th ed. The Iowa State University Press 1967.Google Scholar
  18. Starke, K.: Influence of extracellular noradrenaline on the stimulation evoked secretion of noradrenaline from sympathetic nerves: Evidence for an alphareceptor-mediated feed back inhibition of noradrenaline release. Naunyn-Schmiedeberg's Arch. Pharmacol. 275, 11–23 (1972).Google Scholar
  19. Starke, K., Montel, H., Schümann, M. J.: Influence of cocaine and phenoxybenzamine on noradrenaline uptake and release. Naunyn-Schmiedebergs Arch. Pharmak. 270, 210–214 (1971).Google Scholar
  20. Su, C., Bevan, S. A.: Blockade of the nicotine-induced norepinephrine release by cocaine, phenoxybenzamine and desipramine. J. Pharmacol. exp. Ther. 175, 533–540 (1970).Google Scholar

Copyright information

© Springer-Verlag 1973

Authors and Affiliations

  • Margarita Dubocovich
    • 1
  • S. Z. Langer
    • 1
  1. 1.Instituto de Investigaciones FarmacológicasConsejo Nacional de Investigaciones Científicas y TécnicasBuenos AiresArgentina

Personalised recommendations